Home

MG Clinical Trial

Myasthenia Gravis (MG) is a chronic autoimmune disorder that affects the neuromuscular junction, the connection between nerves and muscles. Recently, CNO has initiated a clinical trial (VIIM study) looking to confirm the therapeutic equivalence or superiority of Efgartigimod, a neonatal FC receptor blocker to IVIG, a standard treatment used in people with generalized seropositive Myasthenia Gravis.
Learn More

MS Protocols

MS Protocols is a concise repository of up-to-date MS treatment information which assembles clinical studies, product monographs, provincial drug coverage requirements, and treatment protocols under a single domain.
Learn More
Learn More

Clinique Neuro - Outaouais

CNO is a multidisciplinary team dedicated to the all encompassing care of people with neurological conditions. Our team is composed of neurologists, clinical and research nurses, physiotherapists, medical assistants and an administration team.
Learn More

Clinical Trials

CNO is involved in clinical research within a wide array of neurological diseases. We believe in contributing to the development of new therapies and adding to the collective understanding of neurosciences and medicine.
Help Us Make Wheelchairs Obsolete
Learn More

Neuro Rehabilitation

NeuroGym® researches and applies evidence-based physical and occupational therapy to enhance recovery from neurological conditions.
Learn More

Repetitive Transcranial Magnetic Stimulation (rTMS)

Using new technology to treat neurological disorders.
Learn More

Infusion Clinic

CNO operates an infusion clinic where patients can receive various intravenous or subcutaneous therapies by experienced nurses under the supervision of onsite medical specialists, following pre-established protocols.
Learn More

Interested in our Clinical Trials

Our clinical research allows us to provide neurological treatments, years before they become accessible to the general population.